Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients. (Q50953894)
Jump to navigation
Jump to search
scientific article published in June 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients. |
scientific article published in June 1997 |
Statements
1 reference
Epalrestat, an aldose reductase inhibitor, improves an impaired generation of oxygen-derived free radicals by neutrophils from poorly controlled NIDDM patients. (English)
1 reference
Sato N
1 reference
Kashima K
1 reference
Uehara Y
1 reference
Ohtani K
1 reference
Shimizu H
1 reference
Mori M
1 reference
1 June 1997
1 reference
1 reference
20
1 reference
6
1 reference
995-998
1 reference
Identifiers
1 reference